Zhuhai Rundu Pharmaceutical Co., Ltd. (002923) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Zhuhai Rundu Pharmaceutical Co., Ltd.

Why is Zhuhai Rundu Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -3.14% and Operating profit at -184.88% over the last 5 years

The company declared very negative results in Mar'25 after flat results in Dec'24

PRE-TAX PROFIT(Q) At CNY 3.21 MM has Fallen at -69.9%
NET PROFIT(Q) At CNY 1.87 MM has Fallen at -81.22%
ROCE(HY) Lowest at 1.07%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 34.65%, its profits have fallen by -196.2%
At the current price, the company has a high dividend yield of 1.2

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Zhuhai Rundu Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Zhuhai Rundu Pharmaceutical Co., Ltd.

-100.0%

0.68

56.04%

China Shanghai Composite

15.19%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-3.14%

EBIT Growth (5y)

-184.88%

EBIT to Interest (avg)

34.30

Debt to EBITDA (avg)

1.60

Net Debt to Equity (avg)

0.35

Sales to Capital Employed (avg)

0.70

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

125.94%

Pledged Shares

Institutional Holding

ROCE (avg)

7.84%

ROE (avg)

8.76%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.11

EV to EBIT

-74.46

EV to EBITDA

38.65

EV to Capital Employed

2.50

EV to Sales

3.36

PEG Ratio

Dividend Yield

1.16%

ROCE (Latest)

-3.35%

ROE (Latest)

-3.20%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-29What is not working for the Company

PRE-TAX PROFIT(Q)

At CNY 3.21 MM has Fallen at -69.9%

NET PROFIT(Q)

At CNY 1.87 MM has Fallen at -81.22%

ROCE(HY)

Lowest at 1.07%

RAW MATERIAL COST(Y)

Grown by 11.04% (YoY

DEBT-EQUITY RATIO (HY)

Highest at 35.65 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 5.43%

NET SALES(Q)

Lowest at CNY 250.85 MM

OPERATING PROFIT(Q)

Lowest at CNY 0.98 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 0.39 %

Here's what is not working for Zhuhai Rundu Pharmaceutical Co., Ltd.

Pre-Tax Profit

At CNY 3.21 MM has Fallen at -69.9%

over average net sales of the previous four periods of CNY 10.65 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 1.87 MM has Fallen at -81.22%

over average net sales of the previous four periods of CNY 9.97 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Net Sales

At CNY 250.85 MM has Fallen at -14.04%

over average net sales of the previous four periods of CNY 291.81 MM

MOJO Watch

Near term sales trend is very negative

Net Sales (CNY MM)

Net Sales

Lowest at CNY 250.85 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY 0.98 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 0.39 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Debt-Equity Ratio

Highest at 35.65 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio

Lowest at 5.43%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 11.04% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales